Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,inventory,accountsPayable,otherCurrentAssets,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,esgPopulated,tradeable,currency,market,shortName,exchange,marketState,priceHint,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,exchangeDataDelayedBy,trailingPE,epsTrailingTwelveMonths,gmtOffSetMilliseconds,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,country,maxAge,address1,fax,industry,address2
t0,GENX,4739562.0,0,37962,,50289,,-72591,850759,809188,-79533,-79533,,,,,,122880,894787,974320,85599,129822,,-72591,-72591,1146945.0,3909350.0,4739562.0,1801034.0,8648912.0,1785.0,3050772.0,431235.0,540060.0,6312420.0,430124.0,3478115.0,540060.0,196097.0,2140395.0,1225433.0,484838.0,13992.0,,195665,-1878473,15397,1843924,-137257,-33342,-4202,5409,15352,-1877221,-7372,-617900,1828527,543302,-1252,-1337720.0,en-US,US,EQUITY,False,Delayed Quote,0.0075,1629993851,0.0,0.008,0.0075,0.0075,25800,0.266,0.007734722,-0.00023472216,-0.030346554,0.016917873,-0.009417873,-0.5566819,91794,0.028195487,15,America/New_York,EDT,False,False,USD,us_market,GENEX PHARMACEUTICALS INC,PNK,POST,4,0.0,0.0075 - 0.0075,0.0075,0.0,0.0,0,0,finmb_10402899,Other OTC,"Genex Pharmaceutical, Inc.",USD,10037,11316,0.0045,1.4999999,0.003 - 0.037,-0.0295,-0.7972973,0.003,0.037,0,0.39473686,0.019,-14400000,-2.03,,,0.037,0.003,0.0077,0.0169,10.04k,11.32k,,,,,,,,,,,,,,,,0.00%,,,4:1,"Jun 30, 2004","Dec 30, 2007","Dec 30, 2007",10.58%,14.40%,4.05%,7.78%,3.24M,0.18,31.80%,2.87M,522.28k,342.55k,0.0190,,430.12k,0.02,574.98k,12.13,0.62,0.27,529.66k,1.25M,Value,300074,Healthcare,86,"Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical is headquartered in Tianjin City, the People's Republic of China.",Tianjin City,86 22 2337 0440,China,86400,1801 Guangyin Building,86 22 2337 9585,Drug Manufacturers—Specialty & Generic,Youyibeilu Hexi District
t-1,GENX,4810246.0,0,158029,,108388,,58766,547652,786863,81182,81182,,,,,,49622,859360,778178,72497,27206,,58766,58766,1146945.0,3032742.0,4810246.0,1067296.0,7842988.0,1785.0,3123363.0,444925.0,538153.0,,463466.0,2587817.0,538153.0,98069.0,7744919.0,6805342.0,476111.0,19726.0,,50879,-547,15397,-224377,155426,-5057,19421,200446,13745,-547,-24426,-37983,-224377,11956,-1252,5157102.0,en-US,US,EQUITY,False,Delayed Quote,0.0075,1629993851,0.0,0.008,0.0075,0.0075,25800,0.266,0.007734722,-0.00023472216,-0.030346554,0.016917873,-0.009417873,-0.5566819,91794,0.028195487,15,America/New_York,EDT,False,False,USD,us_market,GENEX PHARMACEUTICALS INC,PNK,POST,4,0.0,0.0075 - 0.0075,0.0075,0.0,0.0,0,0,finmb_10402899,Other OTC,"Genex Pharmaceutical, Inc.",USD,10037,11316,0.0045,1.4999999,0.003 - 0.037,-0.0295,-0.7972973,0.003,0.037,0,0.39473686,0.019,-14400000,-2.03,,,0.037,0.003,0.0077,0.0169,10.04k,11.32k,,,,,,,,,,,,,,,,0.00%,,,4:1,"Jun 30, 2004","Dec 30, 2007","Dec 30, 2007",10.58%,14.40%,4.05%,7.78%,3.24M,0.18,31.80%,2.87M,522.28k,342.55k,0.0190,,430.12k,0.02,574.98k,12.13,0.62,0.27,529.66k,1.25M,Value,300074,Healthcare,86,"Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical is headquartered in Tianjin City, the People's Republic of China.",Tianjin City,86 22 2337 0440,China,86400,1801 Guangyin Building,86 22 2337 9585,Drug Manufacturers—Specialty & Generic,Youyibeilu Hexi District
t-2,GENX,4543688.0,0,158029,,256022,,157681,449983,650961,200978,200978,,,,,,98341,751104,550126,100143,55044,,157681,157681,1146945.0,2735218.0,4543688.0,1105523.0,7278906.0,1785.0,3064597.0,413630.0,330361.0,,468523.0,2321588.0,330361.0,106994.0,7171912.0,6270642.0,432747.0,11381.0,,-19107,-547,15397,190451,4254,388730,4241,194038,13569,-579,27830,-80310,190451,19232,579,4850324.0,en-US,US,EQUITY,False,Delayed Quote,0.0075,1629993851,0.0,0.008,0.0075,0.0075,25800,0.266,0.007734722,-0.00023472216,-0.030346554,0.016917873,-0.009417873,-0.5566819,91794,0.028195487,15,America/New_York,EDT,False,False,USD,us_market,GENEX PHARMACEUTICALS INC,PNK,POST,4,0.0,0.0075 - 0.0075,0.0075,0.0,0.0,0,0,finmb_10402899,Other OTC,"Genex Pharmaceutical, Inc.",USD,10037,11316,0.0045,1.4999999,0.003 - 0.037,-0.0295,-0.7972973,0.003,0.037,0,0.39473686,0.019,-14400000,-2.03,,,0.037,0.003,0.0077,0.0169,10.04k,11.32k,,,,,,,,,,,,,,,,0.00%,,,4:1,"Jun 30, 2004","Dec 30, 2007","Dec 30, 2007",10.58%,14.40%,4.05%,7.78%,3.24M,0.18,31.80%,2.87M,522.28k,342.55k,0.0190,,430.12k,0.02,574.98k,12.13,0.62,0.27,529.66k,1.25M,Value,300074,Healthcare,86,"Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical is headquartered in Tianjin City, the People's Republic of China.",Tianjin City,86 22 2337 0440,China,86400,1801 Guangyin Building,86 22 2337 9585,Drug Manufacturers—Specialty & Generic,Youyibeilu Hexi District
t-3,GENX,4310142.0,0,158029,,318887,,198693,363918,627428,263510,263510,,,,,,120194,731904,468394,104476,55377,,198693,198693,1146945.0,2284070.0,4310142.0,983452.0,6594212.0,1785.0,2906916.0,45254.0,254496.0,,79793.0,2238816.0,254496.0,118818.0,6475394.0,5676498.0,453722.0,13616.0,262652.0,-59248,-579,540401,-242909,-25759,-112405,1319,129764,13473,-579,11096,-136492,-783310,28193,-579,4236578.0,en-US,US,EQUITY,False,Delayed Quote,0.0075,1629993851,0.0,0.008,0.0075,0.0075,25800,0.266,0.007734722,-0.00023472216,-0.030346554,0.016917873,-0.009417873,-0.5566819,91794,0.028195487,15,America/New_York,EDT,False,False,USD,us_market,GENEX PHARMACEUTICALS INC,PNK,POST,4,0.0,0.0075 - 0.0075,0.0075,0.0,0.0,0,0,finmb_10402899,Other OTC,"Genex Pharmaceutical, Inc.",USD,10037,11316,0.0045,1.4999999,0.003 - 0.037,-0.0295,-0.7972973,0.003,0.037,0,0.39473686,0.019,-14400000,-2.03,,,0.037,0.003,0.0077,0.0169,10.04k,11.32k,,,,,,,,,,,,,,,,0.00%,,,4:1,"Jun 30, 2004","Dec 30, 2007","Dec 30, 2007",10.58%,14.40%,4.05%,7.78%,3.24M,0.18,31.80%,2.87M,522.28k,342.55k,0.0190,,430.12k,0.02,574.98k,12.13,0.62,0.27,529.66k,1.25M,Value,300074,Healthcare,86,"Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical is headquartered in Tianjin City, the People's Republic of China.",Tianjin City,86 22 2337 0440,China,86400,1801 Guangyin Building,86 22 2337 9585,Drug Manufacturers—Specialty & Generic,Youyibeilu Hexi District
